Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: Abacus Diagnostica's GenomeEra C. Difficile Assay


Abacus Diagnostica said recently that it has received the CE mark for the GenomEra C. difficile assay for the detection of toxin-producing Clostridium difficile directly from stool samples.

The GenomEra C. difficile assay is extremely simple to perform directly from stool specimen through a straightforward sample preparation process without extraction, heating or centrifugation steps, Abacus said. The assay is built on rapid and reliable target amplification and end-point detection technology that produces high-quality results in 50 minutes.

The assay runs on the GenomEra CDX system, a closed, self-contained, fully integrated and automated testing platform designed for clinical routine use. The platform combines minimal sample preparation with rapid PCR amplification and end-point detection. It is the first commercial homogenous PCR platform to use thermally stable, intrinsically fluorescent time-resolved fluorometric labels combined with a proprietary assay and measurement technology to eliminate background effects originating from, for example, clinical samples, the company said.

Filed under

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.